Eradication of carriage of Neisseria meningitidis in families: a study in Brazil.
D000293:Adolescent; D000818:Animals; D000900:Anti-Bacterial Agents / Q000627:therapeutic use*; D001938:Brazil; D002353:Carrier State / Q000517:prevention & control*; D002648:Child; D002675:Child, Preschool; D004196:Disease Outbreaks / Q000517:prevention & control; D004352:Drug Resistance, Microbial; D004357:Drug Synergism; D004359:Drug Therapy, Combination; D005500:Follow-Up Studies; D006801:Humans; D007223:Infant; D008589:Meningococcal Infections / Q000188:drug therapy* / Q000235:genetics / Q000517:prevention & control; D008826:Microbial Sensitivity Tests; D008911:Minocycline / Q000009:adverse effects / Q000627:therapeutic use; D009345:Neisseria meningitidis / Q000187:drug effects*; D011817:Rabbits / Q000276:immunology; D012293:Rifampin / Q000009:adverse effects / Q000627:therapeutic use; D013411:Sulfadiazine / Q000009:adverse effects / Q000627:therapeutic use
D000900:Anti-Bacterial Agents; D013411:Sulfadiazine; D008911:Minocycline; D012293:Rifampin